Forma Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. engages in the research, development and commercialization of novel therapeutics for the treatment of hematologic diseases and cancers. Its product pipeline consists of FT-4202 for the treatment of sickle cell disease and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company was founded by Michael A. Foley in December 2011 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Forma Therapeutics Holdings Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Forma Therapeutics Holdings Inc market cap is $957.53M.
What is the 52-week high for Forma Therapeutics Holdings Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Forma Therapeutics Holdings Inc 52 week high is $20.68 as of June 07, 2024.
What is the 52-week low for Forma Therapeutics Holdings Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Forma Therapeutics Holdings Inc 52 week low is $4.95 as of June 07, 2024.
What is Forma Therapeutics Holdings Inc stock price today?
Forma Therapeutics Holdings Inc stock price today is $20.01.
What was Forma Therapeutics Holdings Inc stock price yesterday?
Forma Therapeutics Holdings Inc stock price yesterday was $19.98.
What is the PE ratio of Forma Therapeutics Holdings Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Forma Therapeutics Holdings Inc’s P/E ratio is -5.00.
What is the Price-to-Book ratio of Forma Therapeutics Holdings Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Forma Therapeutics Holdings Inc P/B ratio is 2.3093.
What is the 50-day moving average of Forma Therapeutics Holdings Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Forma Therapeutics Holdings Inc 50-day moving average is $16.85.